VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Lyterian

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 75 out of 100

Co-opting physiologically relevant protein homeostatic mechanisms for treating disease

Also known as Lyterian Therapeutics

  • Biotech & therapeutics
Status
Operatingas of 2026-09-18
Business model
B2B
Headquarters
South San Francisco, CA, United States
Open relationship map
Claim, correct or request removal

Record updated 28 September 2026

About

Lyterian Therapeutics is committed to developing transformative medicines for patients by co-opting physiologically relevant protein homeostatic mechanisms to regulate genetically-validated targets.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy